ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_2_2713 # 3560669 # 3564733 # 1 # ID=2_2713;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.534	scaffold_2_2713	3560669	3564733	+	Strict	32	34.2686	Trimethoprim-resistant dihydrofolate reductase DfrA42	34.43	3005334	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGAAACACACGTCCGGAGTGTCCAGACTGTCCTGTCTAGATCTGAGCAGATATACCGTAACGTGGCAGGTTACTCCCGGTCAACGATTGCCTCCTTGGACCGGAATGATCTTCACCATGCCGGCCATCTGATCCGGGACATCTCGGCGAGCCTTTATCAAATACACCTCATTCTCTCTACCGCGCAAGATGATGATGACTCCACTAGCCAAGAGAACTTCGACTTATACCATATTCAGCGCTGTCAACGACTTCTTGACGACCTCGACCAGTCCATTAGCCTTGGCCATCTGGACTGCCTACATGGACGACCATCAGAAGGGAAACAAGCAGACCCCTTAGTCCGAGATCTCTCGCATCTCCATGCCCAACTCGTCTTGGCTGTCGCCGCTGATACGCCGTTCGCACTCCTGCGGGTGCTGTCGCAGCCCAAGATGCTGACTGTGCCTGGCCAGGCAACTTTCAATGTACACTTGCCTGACAGAGTCCCGAGCGGCCACAGACGAGATATTACTACAGTACGTGGCATTCCAAATCCGGCTGCAGTGGCACAGTGGTCCGACAGTCGCCTTAATACCTATTTGAGGCTAAGAACACCAGGGTCCCTCGATTTGACATTGCAACACCTCTTGATACAAGATTGGCTGGGAGGCCGTGTGGCTCGACTGTGGCTTCATGGGGAGCGAGGAACTGGCAAGACCATCCTGGCGAGCGCAATCTTGGAGCAGCTGATACACCAAACAAGGAATGATCCGACTACCGCCGTCTGTTACCATATTTTCGACCAGCCAAAACGATGGGGCGCAGGATCAAATGCGCTGCTCGCTGGCTTGATCGGTCAACTTGCCCAACAAAATCTAGATGCACAACTAAGCATCAGGGTTGGGTTGAATCCGGATCTCCTTCCAGCCAGGCTCCCTCAATGGCTGGAGGACTCTCCTAATGGAGGCATAGCGTCTTCGCGAGAGCAAGTCGACTACCTCGGCCACATTTTCAAGACTATTGAGGCAATGTATGAAAGGCTGTATATTGTCATTGATGGTATTGATGAGGGTGGCGTAGAAAGTATGGAGGCACTGGCCATTCTACACAACTACGTCCGGGCAAGCACGGCATATGGAACTCCTGTCACGAGTATGTTGGTCCTAAGCCGTGAACCTCCGGATGCAAAGGGCGACTTTCGCATCCCGCGTGCCCGTTATAAGACCCTGGATATCACGCCTGACCCCTCCCAGATCAAGCTGTATGTCAAAAATCGGCTTCAAGAACACAGACAAGTTCGCTCAACATTCAGCGATAGCTCAAAAGAAGGAGAGCGGATTGTGGAAGCCATTGGCTCTGCAACTCGGTTGTTCGAGGTTGCCGAGCTTCAAATCGACTACCTGCTATCCCTCACTTCTGAAGCAGAGAGAAACTTTGCACTGCTCAAGTTGCCCACAGAGCTTCAGAAGATGTATTCGCTCTTCATAGCGAGGCTTACGAATCCGTACGAGCGGGATCTTGTCCACACCACGTTGCGATGGTTGCAGGAGTTAGGACCCGACGAGCTCGACATGTATCAACTTTGCGAAGGTATCGCCATTTTCCTTGCGAAGGGAGCAGAATCACTGGCCGACGTACCCGCAGTGACTCAGGCACAGATCCTTCGTCTATGTGGAGGCCTTGTAAGGAGGACACTAGACGGATCGACTATCGAGCTTGCACACCAAAGTGTTCAAGAAATGTTATCGGTACATACTCTCGACGCCAGGTGTGAGATTGGCATCGCATGTCTTCGTCTTCTGAATCTCAGGGATTTCGCTTGTGCTCCCAAGGAATTCCGGCTCGAGCAAGGGCATTCTAGTCGGCGCGATGCATCCCATCCCTTTTATCAGTATGCTACCGAGGCATGGATGGACGTGCTACCTGGCAAAGACGTTGAAGAAGCGCTTGAAGAAGTGTATATGAAGGAAGCATGCCAACTATTTACTTCCCTTCGGTCAGGGAATCTGGTCTCATGGCTTCTTGAGGTGGGCAAGCGAATATTCGATGCGGCGTTACCCCTTTCGCCGGCACAGATCTTCATCTGTTTGACAACCGTGTGCACCAAATACAGGCTGTCGTCAACGCACATTGCGGCGTGCTTCGGACTATCTCGTGTTTGTAGCGCCTTGGTCCAAGGTGGGTTGGATATAAACGCTAGATGTGAGCTAGGCACCCCATTGTATTGTGCGCTTGCCGGTCCGGTGTTGCTCCTTTTCGATGGGCTGAACATTGACTGGGCGATCGCCCGAAAGATGATTCGCCTCGAGTCACGCCTTGACACAGCGGAGAAGTTGATGGAGCTCGGCGCACAGCCGGATTCTGTACCGTGGCGACCCGACACACACCTATCGTTTCCTGCTGTCGCCCTGATGGCTTGCGCCGCAAGATCTGGCTCTGGAGACGTCAGACTCTTCACGTCTCTATGCCCAGATGGCCAGTATCTCGAGGACGATCACTTCTATACAATCTTTCAAGATCGAGCATTTCCATTTGAGCCTTCGAACTCTGGCAGTAGCGATGACCTCGTGGCGCCGCACCAGAAGCAGTTTCTCGACGATCTGTGCATCTTGCTAATTGACCAATCATGGAAAAATCGCATTTCGAGGATCTGGGCTACTGCTTGGAAGAAAGGCATTGATCACAACCTGCAATGTATATCCCCGGCGACGCGGCGTCGACTTCCGTTGGACGACGAAGCGTTTGCCAAGGCTATGACCGATGCACTTCAGACAGGATCGGAGGTTGATATTCGATATTGCATGCAGGACACTCGATGGAATGCTAACCTGCCTTTGACTGGTGTGGCAGAGGAGGACCGCGGCCGGACGCTCCTGCACCGAGCTGTGGAAGAGGGTGACGTTTCCTTGGTGCGCTTGCTTCTGAGGCGTGGTAGAGTAGATGTCTCGATCTCTGACGCATCTGGGCGGACTCCGCTGCATCTTTGTGAGAGGAGCGATGTGCTGAGACTTCTCGTCGGTAGCGGCGCCGACCTTCACCAAGTTGACAACGACGGCCGTCTGCTGTGGCACTACGCAGCTGCAAATAACGACATCCTCCTACTGCGAACACTCCTGGCGCTCGACCCTGATACGGAATGGGTATTCAAACAGACGACAAAGCAAGGGAGAACGCCACTGGCAGAGGCTCTCGCATATGTTCGTGAGCTTAACGGCCTACCCACAGTTCCACCCGGCCAGTATCGTCAGTTCTTGACGGAGAAGACACAGTCTATAAGGTTCATACTGGGTCGGATTGGCTATGATACCGCTTGTCTACGCAGTGACCTTCCTATTGTTTGTTATGCTGCTGAATGGGGGGAACAATGGATGGTGAGGACCCTCCGGCGACAGTCTCCCGTGCTGGACGTGGCCACAAAGGATGGGTCAGGCCCCCTGCATTTCCTCAACTTCCATACGACCTCCGAACTGATTCGGGAGATCAAGGAGATCCCGGGCGTTATCGACCTTCCTGTTCTGAACAGTGATGGCCGCAGCCCTGCCGAGACAATCTTCCTCGCCTTCAAGCCCAGTATTGAAGAACCCAACGACAATGCACATCCATCCAACAATGCAGCGTTGGATAGGATAGCATATATGGAGCTACTGACCGAGGAAGTCTGCAAGTCTCGGGACGAACAGGGCAGGACGCTCTGGGAACGATTCTGCCGCGATGTTGTCCTCTACTATGCCGCAAAGAAAGCCTGGCGCCGCGTCGCCGATGCGATAACGGTGGCGGTGAGCTGTTTCGTTGAGAGAGGAGTGGTGCGGGAGTATGAAACTTTGTCGGGACATTGCGCGTTCTTCGAGTTGTTGCGCATGATCTGCGGCGATTTCACCCGCGTCGGCATGCCCTCGTGGCTTCCTGCGATCTACCTGCAGTTGATTCGAGCCACGACCAGCATGAAGATTCAGCTACTGAAAGATGACCCCGGTATCTACTCCTTCCTGCAGCTGATGCAGCGCCGGGATGCGTTTGAATACCGGGAACTCTTTACAGTGTTAGACTCAATGGGCGTTCCGATCGTGAATTCACCTGGGTGA	METHVRSVQTVLSRSEQIYRNVAGYSRSTIASLDRNDLHHAGHLIRDISASLYQIHLILSTAQDDDDSTSQENFDLYHIQRCQRLLDDLDQSISLGHLDCLHGRPSEGKQADPLVRDLSHLHAQLVLAVAADTPFALLRVLSQPKMLTVPGQATFNVHLPDRVPSGHRRDITTVRGIPNPAAVAQWSDSRLNTYLRLRTPGSLDLTLQHLLIQDWLGGRVARLWLHGERGTGKTILASAILEQLIHQTRNDPTTAVCYHIFDQPKRWGAGSNALLAGLIGQLAQQNLDAQLSIRVGLNPDLLPARLPQWLEDSPNGGIASSREQVDYLGHIFKTIEAMYERLYIVIDGIDEGGVESMEALAILHNYVRASTAYGTPVTSMLVLSREPPDAKGDFRIPRARYKTLDITPDPSQIKLYVKNRLQEHRQVRSTFSDSSKEGERIVEAIGSATRLFEVAELQIDYLLSLTSEAERNFALLKLPTELQKMYSLFIARLTNPYERDLVHTTLRWLQELGPDELDMYQLCEGIAIFLAKGAESLADVPAVTQAQILRLCGGLVRRTLDGSTIELAHQSVQEMLSVHTLDARCEIGIACLRLLNLRDFACAPKEFRLEQGHSSRRDASHPFYQYATEAWMDVLPGKDVEEALEEVYMKEACQLFTSLRSGNLVSWLLEVGKRIFDAALPLSPAQIFICLTTVCTKYRLSSTHIAACFGLSRVCSALVQGGLDINARCELGTPLYCALAGPVLLLFDGLNIDWAIARKMIRLESRLDTAEKLMELGAQPDSVPWRPDTHLSFPAVALMACAARSGSGDVRLFTSLCPDGQYLEDDHFYTIFQDRAFPFEPSNSGSSDDLVAPHQKQFLDDLCILLIDQSWKNRISRIWATAWKKGIDHNLQCISPATRRRLPLDDEAFAKAMTDALQTGSEVDIRYCMQDTRWNANLPLTGVAEEDRGRTLLHRAVEEGDVSLVRLLLRRGRVDVSISDASGRTPLHLCERSDVLRLLVGSGADLHQVDNDGRLLWHYAAANNDILLLRTLLALDPDTEWVFKQTTKQGRTPLAEALAYVRELNGLPTVPPGQYRQFLTEKTQSIRFILGRIGYDTACLRSDLPIVCYAAEWGEQWMVRTLRRQSPVLDVATKDGSGPLHFLNFHTTSELIREIKEIPGVIDLPVLNSDGRSPAETIFLAFKPSIEEPNDNAHPSNNAALDRIAYMELLTEEVCKSRDEQGRTLWERFCRDVVLYYAAKKAWRRVADAITVAVSCFVERGVVREYETLSGHCAFFELLRMICGDFTRVGMPSWLPAIYLQLIRATTSMKIQLLKDDPGIYSFLQLMQRRDAFEYRELFTVLDSMGVPIVNSPG	MHKPTPLKRLSMILARDLNGAIGYEGSLAIKSDNDFAWYKKITKPFKHAVCGRVTYEEDLPDIVKKRHRFIIITRNPDKYASTPEAQYMTLSDALKELQVWDVPGHDIICLGGAEIYKALLPYVSTVYLTTFFSVADEADTYFNDFTDKWESVGATWFNDCYCTRLERVCQSTNNII	764.97	gnl|BL_ORD_ID|3105|hsp_num:0	4066		
scaffold_3_51 # 90474 # 91049 # 1 # ID=3_51;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.543	scaffold_3_51 	90474	91049	+	Strict	200	23.483	RbpA	100.0	3000245	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target protection	RbpA bacterial RNA polymerase-binding protein	ATGAAGTTTGTGGATGAAGGGCCGAGACTGCAGCGCTCAGCCAAGAAGGCCAGTGTCCGTTCCTCGAGAATTTCGTCATCCAAGCCCTCCAGCTTGCCAGCCAGGGCTTCGGCTCCAGTTACAACTACTGCACCTAGTGGTGAATGTGCAATCTCCGGTACAGCGGTCCAAAAACTACCCCCTCGAACACACTGGGACACCCAAGTGCATCATCTCAACTCATCTAAACTAGACCGAGACCAGATACTGTCAGTATTTGTGTCAGCTATGTTCCCTCTCGGGAGCAGTTCAGCACAGAGCTCGTTTCTCGGGAGTTGGTTGTGGCATGTGCCATTGCGGCTTGGCTCGAGTGCCGTTCTCGATCACGCGGCGCTGTCACTCGCCCTGGCATATTTCGCTCGACTATCTGGGGATCAACTCGTGCTTCGGAACGCAGAGCTGTCATATGCTATTGCTTTGAGGAGTCTAACGGCGGCCATATCAGATCCGGACAACCGGCTTGCCTCAGAGGTGCTGTGCGCGGTATTGCTCCTTGGACATTATGAGGTCTGTACAGCTCGACCCGACAAGCTTTAG	MKFVDEGPRLQRSAKKASVRSSRISSSKPSSLPARASAPVTTTAPSGECAISGTAVQKLPPRTHWDTQVHHLNSSKLDRDQILSVFVSAMFPLGSSSAQSSFLGSWLWHVPLRLGSSAVLDHAALSLALAYFARLSGDQLVLRNAELSYAIALRSLTAAISDPDNRLASEVLCAVLLLGHYEVCTARPDKL	MADRVLRGSRLGAVSYETDRNHDLAPRQVARYRTDNGEEFDVPFADDAEIPGTWLCRNGLEGTLIEGDVPEPKKVKPPRTHWDMLLERRSVEELEELLKERLDLIKAKRRGTGS	167.54	gnl|BL_ORD_ID|1340|hsp_num:0	1425	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_229 # 325839 # 325982 # -1 # ID=4_229;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.528	scaffold_4_229 	325839	325982	-	Strict	400	20.7866	GIM-2	100.0	3003194	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	GIM beta-lactamase	ATGGTCCAGCTCGCAGCCCTGACGATGAGGAAAAAAGACAAAGAGAGTACAGAACCATTCCAAGACAGCACTCATAGCCATGGCGACCTTTGCAAGCGACTCGAACACCGCCGAAATGGGCCGAGCGAGAAGCCATACCATTGA	MVQLAALTMRKKDKESTEPFQDSTHSHGDLCKRLEHRRNGPSEKPYH	MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQAYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHGDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKLMQPTAEASAD	18.80	gnl|BL_ORD_ID|1529|hsp_num:0	1623	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_1855 # 2504358 # 2504447 # -1 # ID=4_1855;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656	scaffold_4_1855 	2504358	2504447	-	Strict	1200	20.7866	tet(44)	100.0	3000556	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAATGACCTGACCAACGGCCAGGCCGTCTTCCTCGGCCGTGTCGACGCCGCTGTCGCCCAGGTCGACCTCAGCAACTGTGGCCTGTAG	MNDLTNGQAVFLGRVDAAVAQVDLSNCGL	MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAVTSFNWNDYKINIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKIDQDGINLNNIYQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQELMYEEYRCVKKGSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRLYSGTLHLRDTIILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWNDKTVPILRTRIEPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHINIRIEDPTVIYLEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREGINYGLEQGLYGWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGYFSRAYKDAQKHCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQSRRPNNRIDKVRHMFNKKEN	4.53	gnl|BL_ORD_ID|1106|hsp_num:0	1171	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_669 # 862560 # 862736 # 1 # ID=5_669;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.554	scaffold_5_669 	862560	862736	+	Strict	750	23.8682	CMH-1	100.0	3004777	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CMH beta-lactamase	ATGACTTTGGGGATCGATGTCGTCGACACGCCCACCGCGTTCCAACACGTCAGTCCCGATGCCTTCGTGTTTGGAATACATCTCCCCCACTATGCCTGGGGCTATGCATTGAGTGACCATCTCCCGGGCCTCTACATCGGGACGGATCTAGAATCGCTGGATAGGTCAGTCTACTAG	MTLGIDVVDTPTAFQHVSPDAFVFGIHLPHYAWGYALSDHLPGLYIGTDLESLDRSVY	MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ	15.22	gnl|BL_ORD_ID|2700|hsp_num:0	3576	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_1952 # 1842648 # 1842758 # 1 # ID=6_1952;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.604	scaffold_6_1952 	1842648	1842758	+	Strict	550	20.0162	GOB-12	100.0	3004804	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	ATGCTACTAGTTGTGACCGTCCACCCGGGACACACAAAGGAGGTAAAGAACGATGGGCGCACCGGTGTGGTGGTCCCAGGTCCGTCATTCAGGCGGACCGTGTGGGGCTAG	MLLVVTVHPGHTKEVKNDGRTGVVVPGPSFRRTVWG	MRNFATLFFMFVCLGLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGKSDYEMGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK	12.41	gnl|BL_ORD_ID|2392|hsp_num:0	3598	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_8 # 16637 # 16726 # -1 # ID=7_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.467	scaffold_7_8 	16637	16726	-	Strict	750	18.8606	tet(33)	100.0	3000478	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCCCACAAACGTGTTGACATACATCAACGCCGACATTGGTAAGCTCCCATCATGCTGCGAGCAAGAAACCGAGAGCAACTGTAACTAA	MPTNVLTYINADIGKLPSCCEQETESNCN	MSSLTSARGSLATVLITASLDAAGMGLVMPILPALLHEAGVTADAVPLNVGVLIALYAVMQFIFAPVLGTLSDRFGRRRVLLVSLAGATVDYLVLATTSALSVFYIARAVAGITGATNAVTATVIADITPPHQRAKRFGLLSACYGGGMIAGPAMGGLFGAISPHLPFLLAALLSASNLALTFILLRETRPDSPARSASLAQHRGRPGLSAVPGITFLLIAFGLVQFIGQAPGATWVLFTEHRLDWSPVEVGISLSVFGIVQVLVQALLTGRIVEWIGEAKTVIIGCITDALGLVGLAIVTDAFSMAPILAALGIGGIGLPALQTLLSQRVDEQHQGRLQGVLASINSVTSIFGPVAFTTIFALTYINADGFLWLCAAALYVPCVILIMRGTAASPKFGSWASGDSM	7.13	gnl|BL_ORD_ID|1975|hsp_num:0	2046	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_862 # 1043853 # 1043978 # -1 # ID=7_862;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.524	scaffold_7_862 	1043853	1043978	-	Strict	400	20.4014	CatU	100.0	3003983	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGGTCACGGCGTCATCAGAAGAGACACTCGTCGCCGATACCCAGGGATGGACGAAGGGAGGTGATATGGAGCAGTATCGGGACAGAACTGCATATCACTATATGGGAGAACATAGAGGGACATGA	MVTASSEETLVADTQGWTKGGDMEQYRDRTAYHYMGEHRGT	MKFHIINVEEWTRKPYYEHYLRSNKCTFSITVDIDITRLLYSLKANGFKLYPAFIYMVTRVVNDRVEFKTSFSPEGELGYWDRMTPSYTFFHNDDHTFSCLWTAFSNDFYRFHDHYEQDMEQYRDTKGLFVKENPPPNTFPISMIPWTSFSGFNLNIVNEADYLLPIITGGKYTEQGGRVLLPVSLQVHHAVCDGYHASMFFKELQSLADSFEDWLT	18.89	gnl|BL_ORD_ID|2289|hsp_num:0	2520	True	loose hit with at least 95 percent identity pushed strict
scaffold_22_195 # 263998 # 264204 # -1 # ID=22_195;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=13bp;gc_cont=0.440	scaffold_22_195 	263998	264204	-	Strict	500	23.483	FomA	100.0	3000423	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	Fom phosphotransferase family	ATGCTGCTATTAGACGAAGTTTGGCTCTCAGTACTTTACTATGTGTGTGACGTTCAGCAACAGTCACCGCTGGTCTCCAAATACCTTATCCTACCTGTGCGAGAAGTTATCATCGTGGTTAGCTCATCTGATCATGATAGTACTCATGCCTTTATTTACTCCTTCGTACGATATATTGCATCGTGCCACAACAGGCATCCTGAATAG	MLLLDEVWLSVLYYVCDVQQQSPLVSKYLILPVREVIIVVSSSDHDSTHAFIYSFVRYIASCHNRHPE	MTPDFLAIKVGGSLFSRKDEPGSLDDDAVTPFARNFARLAETYRGRMVLISGGGAFGHGAIRDHDSTHAFSLAGLTEATFEVKKRWAEKLRGIGVDAFPLQLAAMCTLRNGIPQLRSEVLRDVLDHGALPVLAGDALFDEHGKLWAFSSDRVPEVLLPMVEGRLRVVTLTDVDGIVTDGAGGDTILPEVDARSPEQAYAALWGSSEWDATGAMHTKLDALVTCARRGAECFIMRGDPGSDLEFLTAPFSSWPAHVRSTRITTTASA	25.56	gnl|BL_ORD_ID|191|hsp_num:0	206	True	loose hit with at least 95 percent identity pushed strict
